All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Immunosuppressants

Fabhalta

(iptacopan)

Uses, side effects, dosage information & price range

Novartis Europharm Limited

About this medicine

Paroxysmal nocturnal haemoglobinuria Fabhalta is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia. Complement 3 glomerulopathy Fabhalta is indicated for the treatment of adult patients with complement 3 glomerulopathy (C3G) in combination with a renin-angiotensin system (RAS) inhibitor, or in patients who are RAS-inhibitor intolerant, or for whom a RAS inhibitor is contraindicated (see section 5.1).

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

Pomalidomide ZentivaComposition: pomalidomideZentiva, k.s.
Price on RequestView Details →
UpliznaComposition: inebilizumabAmgen Europe B.V.
Price on RequestView Details →
VeblocemaComposition: infliximabCelltrion Healthcare Hungary Kft.
Price on RequestView Details →
AravaComposition: leflunomideSanofi-aventis Deutschland GmbH
Price on RequestView Details →
CimziaComposition: certolizumab pegolUCB Pharma
Price on RequestView Details →

Key Information

Salt / Composition

iptacopan

Category

Immunosuppressants

Manufacturer

Novartis Europharm Limited

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.